-+ 0.00%
-+ 0.00%
-+ 0.00%

Benitec Biopharma Q2 EPS $(0.26) Misses $(0.22) Estimate

Benzinga·02/12/2026 14:07:33
Listen to the news
Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.26) per share which missed the analyst consensus estimate of $(0.22) by 16.59 percent. This is unchanged from the same period last year.